Caesarstone Earnings Call Transcripts
Fiscal Year 2026
-
Gross margin improved despite a 15% revenue decline, driven by restructuring and cost savings. Australia showed strong growth, while North America and EMEA faced demand softness. On track for positive adjusted EBITDA in Q3 2026, with ongoing risks from tariffs and litigation.
Fiscal Year 2025
-
Q3 2025 revenue declined 5.7% year-over-year to $102.1 million, with losses widening and gross margin down. Strategic transformation, including full outsourcing and Bar-Lev closure, is expected to yield over $85 million in annualized savings and a return to positive adjusted EBITDA by Q3 2026.
-
Second quarter revenue declined 15.6% year-over-year due to global economic headwinds, with gross margin and EBITDA also down. Cost-saving initiatives and strategic transformation continue, while risks include U.S. tariffs and ongoing silica-related litigation.
-
Q1 2025 saw revenue and margins decline year-over-year due to global headwinds, but sequential improvement and cost savings reflect progress in transformation. U.S. tariffs and ongoing lawsuits pose risks, while a strong balance sheet supports continued investment.
Fiscal Year 2024
-
Q4 and full year 2024 saw revenue declines but improved gross margins and strong cash flow, driven by operational restructuring and cost savings. Ongoing silicosis litigation remains a risk, while 2025 is expected to bring modest EBITDA improvement and further cost efficiencies.
-
Q3 revenue fell 24.8% year-over-year amid global market weakness, but gross margin improved due to manufacturing optimization and cost controls. Cash flow was boosted by asset sales, while ongoing cost pressures and litigation risks persist.
-
Q2 2024 revenue fell 16.9% year-over-year, but gross margin improved to 22.9% due to restructuring and cost efficiencies. Higher shipping and material costs are expected to weigh on H2 results, with full-year adjusted EBITDA now forecast as a mid-single-digit million-dollar loss.